Replies to post #722019 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Various types of immune cells were activated as shown in the poly-iclc trial. CD4 t-cells even outnumbered CD8 t-cells. NK cells were activated too. Merck recruited a researcher with research direction on using DC vaccines which activate NK cells to treat HIV.

The poster is an illiterate who has no respect for science.

[georgebailey]

Oncovir is uniquely positioned…..to add significant clinical value….to dendretic cell vaccines

NOTsubtle foreshadowing.